Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06646757 · ClinicalTrials.gov registry record · NA
Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 803
- Enrollment target
NCT06646757: Completed NA study, sponsored by University of Pennsylvania.
NCT06646757 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 803 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06646757, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 803 participants
- Enrollment target
Study Summary
EMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability. This multisite, randomized controlled trial with 16 arms will randomize adults with moderate-to-severe IBD-related disability to a combination of four multimodal behavioral interventions to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy. The interventions are four existing, publicly available disease-specific self-help resources offered at no cost to the participants: a book, smart app, help center, and peer mentor. Participants will complete online surveys and may engage in virtual focus groups. Participants may receive an honorarium (e-gift card) and/or be entered into a lottery for a giftcards post-survey completion and focus group participation.
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL HELP
- BEHAVIORAL APP
- BEHAVIORAL PEER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 803 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2025-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06646757
The ClinicalTrials.gov registry entry for NCT06646757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 803 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which CBT is the first listed.
NCT06646757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06646757 about?
NCT06646757 is a clinical study titled "Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability". EMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability. This multisite, randomized controlled trial with 16 arms will randomize adults with moderate-to-severe IBD-related disability to a combinat...
What is the current status of trial NCT06646757?
This trial is currently completed. It is a NA study. The enrollment target is 803 participants. The study started on 2024-08-14. Estimated completion is 2025-10-15.
What interventions are being tested in trial NCT06646757?
The interventions under investigation include: CBT (BEHAVIORAL), HELP (BEHAVIORAL), APP (BEHAVIORAL), PEER (BEHAVIORAL).
Who is sponsoring clinical trial NCT06646757?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.